After recovering from Oropouche infection, symptoms recur in about 60% of patients within a few days up to several weeks.

Scientists at IIT Roorkee have achieved a major breakthrough by identifying a potential drug for the treatment of chikungunya ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

Rising temperatures are driving the expansion of the tiger mosquito into Europe and increasing the prevalence of toxic plants ...

In January, the county launched a program designed to lower the mosquito population by sterilizing male mosquitos with low ...

Jaipur: With the onset of summer, mosquito-borne illnesses have begun appearing in the city.The health department has ...

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

The following is a summary of “Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory joint disease,” published in the February 2025 issue of Scientific Reports ...

Five people have been hospitalized with cardiac and neurological symptoms after getting the chikungunya vaccine.

(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been hospitalized. On Tuesday, the U.S. Centers for Disease Control and Prevention ...